Trial Profile
Effects of dexmedetomidine on postoperative outcome in children with trisomy 21 undergoing congenital heart disease surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Adverse reactions
- 04 May 2016 New trial record